España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Biogen
BIIB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$140.55
-0.68
-0.48%
At close: -
$140.50
-0.05
-0.04%
After Hours: Jan 17, 5:18 PM EDT
Get Report
Comment
Biogen (BIIB) Forecast
News
Earnings
Biogen (BIIB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Biogen (NASDAQ:BIIB) Stock
Biogen Stock (NASDAQ: BIIB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 17, 2025
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Anthony Noto
Tuesday, January 14, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Vandana Singh
Reported Earlier, Eisai And Biogen Announced ...
Benzinga Newsdesk
Monday, January 13, 2025
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
Vandana Singh
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
Avi Kapoor
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?
Vandana Singh
Reported Saturday, Sage Therapeutics Confirms...
Benzinga Newsdesk
Friday, January 10, 2025
Wells Fargo Maintains Equal-Weight on Biogen,...
Benzinga Newsdesk
Thursday, January 09, 2025
Peering Into Biogen's Recent Short Interest
Benzinga Insights
Wednesday, January 08, 2025
Truist Securities Maintains Buy on Biogen, Lo...
Benzinga Newsdesk
Tuesday, January 07, 2025
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
Vandana Singh
Friday, January 03, 2025
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
Vandana Singh
Thursday, January 02, 2025
17 Analysts Assess Biogen: What You Need To Know
Benzinga Insights
Piper Sandler Downgrades Biogen to Neutral, L...
Benzinga Newsdesk
Friday, December 20, 2024
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor
BMO Capital Downgrades Biogen to Market Perfo...
Benzinga Newsdesk
Wednesday, December 11, 2024
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory?
Surbhi Jain
Tuesday, December 10, 2024
B of A Securities Reinstates Neutral on Bioge...
Benzinga Newsdesk
Monday, December 09, 2024
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Vandana Singh
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Avi Kapoor
Assessing Biogen: Insights From 19 Financial Analysts
Benzinga Insights
Jefferies Downgrades Biogen to Hold, Lowers P...
Benzinga Newsdesk
Thursday, December 05, 2024
GeneDx Announces Biogen, Praxis Precision Med...
Benzinga Newsdesk
Wednesday, December 04, 2024
Biogen Announces LEQEMBI Approved For The Tre...
Benzinga Newsdesk
Tuesday, December 03, 2024
Biogen Exec Says Co Expects "A Linear Trend" ...
Benzinga Newsdesk
Monday, December 02, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, November 29, 2024
Reported Wednesday, Eisai and Biogen Introduc...
Benzinga Newsdesk
Tuesday, November 26, 2024
Smart Money Is Betting Big In BIIB Options
Benzinga Insights
Thursday, November 21, 2024
Mizuho Maintains Outperform on Biogen, Lowers...
Benzinga Newsdesk
Wednesday, November 20, 2024
Biogen Unusual Options Activity For November 20
Benzinga Insights
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Vandana Singh
Tuesday, November 19, 2024
UCB And Biogen Present Phase 3 Data On Dapiro...
Benzinga Newsdesk
Monday, November 18, 2024
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Vandana Singh
This Biogen Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Avi Kapoor
Biogen shares are trading lower after Needham...
Benzinga Newsdesk
Needham Downgrades Biogen to Hold, Maintains ...
Benzinga Newsdesk
Friday, November 15, 2024
Biogen Unusual Options Activity
Benzinga Insights
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Baird Maintains Outperform on Biogen, Raises ...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Biogen w...
Benzinga Newsdesk
Thursday, November 14, 2024
CHMP Recommends EU Approval For Eisai's Leqem...
Benzinga Newsdesk
Peeling Back The Layers: Exploring Biogen Through Analyst Insights
Benzinga Insights
Citigroup Initiates Coverage On Biogen with N...
Benzinga Newsdesk
Monday, November 04, 2024
Evaluating Biogen: Insights From 17 Financial Analysts
Benzinga Insights
JP Morgan Maintains Neutral on Biogen, Lowers...
Benzinga Newsdesk
Friday, November 01, 2024
Reported Earlier, Eisai And Submit LEQEMBI BL...
Benzinga Newsdesk
Thursday, October 31, 2024
Oppenheimer Maintains Outperform on Biogen, L...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Biogen, Lo...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch